MIF (Pro-Leu-Gly-NH2): failure to affect oxotremorine effects in mice and rats as well as fluphenazine catalepsy or amphetamine hyperactivity in rats.
D000661:Amphetamine / Q000037:antagonists & inhibitors*; D000818:Animals; D002375:Catalepsy / Q000139:chemically induced; D005476:Fluphenazine / Q000037:antagonists & inhibitors*; D006801:Humans; D009075:MSH Release-Inhibiting Hormone / Q000494:pharmacology*; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010095:Oxotremorine / Q000037:antagonists & inhibitors*; D010455:Peptides / Q000494:pharmacology*; D051381:Rats; D014202:Tremor / Q000139:chemically induced
D010455:Peptides; D010095:Oxotremorine; D009075:MSH Release-Inhibiting Hormone; D000661:Amphetamine; D005476:Fluphenazine